SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-030179
Filing Date
2021-12-01
Accepted
2021-12-01 15:39:47
Documents
19
Period of Report
2021-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43315
2 ex5-1.htm EX-5.1 17852
3 ex10-1.htm EX-10.1 200263
4 ex10-2.htm EX-10.2 58230
5 ex10-3.htm EX-10.3 14497
6 ex99-1.htm EX-99.1 11259
7 ex5-1_001.jpg GRAPHIC 4344
8 GRAPHIC logo_001.jpg GRAPHIC 3506
  Complete submission text file 0001493152-21-030179.txt   604043

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qlgn-20211129.xsd EX-101.SCH 3034
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qlgn-20211129_lab.xml EX-101.LAB 34916
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qlgn-20211129_pre.xml EX-101.PRE 22795
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3646
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 211462767
SIC: 2834 Pharmaceutical Preparations